Literature DB >> 9514903

Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells.

H Kojima1, M Takeuchi, T Ohta, Y Nishida, N Arai, M Ikeda, H Ikegami, M Kurimoto.   

Abstract

The pleiotropic biological activities of interleukin-18 (IL-18) are mediated by IL-18 receptor (IL-18R). When the ligand binds to the IL-18R, IL-18R initiates a signaling cascade that results in the activation of nuclear factor kappa B (NF-kappa B). When mouse EL-4 cells were exposed to IL-18, IL-1 receptor-associated kinase (IRAK) was recruited to IL-18R and was phosphorylated. In addition, tumor necrosis factor receptor-associated factor-6 (TRAF6) was associated with IRAK. Therefore, we concluded that IL-18/IL-18R-mediated signaling may share the IRAK/TRAF6 pathway through NF-kappa B activation with the IL-1/IL-1 receptor system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514903     DOI: 10.1006/bbrc.1998.8236

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit.

Authors:  Xiangzhi Meng; Michael Leman; Yan Xiang
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

2.  Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase.

Authors:  X Li; M Commane; C Burns; K Vithalani; Z Cao; G R Stark
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 3.  Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.

Authors:  Laura C O'Brien; Eleonora Mezzaroma; Benjamin W Van Tassell; Carlo Marchetti; Salvatore Carbone; Antonio Abbate; Stefano Toldo
Journal:  Mol Med       Date:  2014-06-12       Impact factor: 6.354

4.  Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation.

Authors:  Sanjita Banerjee; Judith S Bond
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

5.  Interleukin 18 stimulates HIV type 1 in monocytic cells.

Authors:  L Shapiro; A J Puren; H A Barton; D Novick; R L Peskind; R Shenkar; Y Gu; M S Su; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 6.  IL-18 in inflammatory and autoimmune disease.

Authors:  Saikiran K Sedimbi; Thomas Hägglöf; Mikael C I Karlsson
Journal:  Cell Mol Life Sci       Date:  2013-07-27       Impact factor: 9.261

7.  IL-18 synergizes with IL-7 to drive slow proliferation of naive CD8 T cells by costimulating self-peptide-mediated TCR signals.

Authors:  Matthew C Walsh; Erika L Pearce; Pedro J Cejas; JangEun Lee; Li-San Wang; Yongwon Choi
Journal:  J Immunol       Date:  2014-09-08       Impact factor: 5.422

8.  A comprehensive pathway map of IL-18-mediated signalling.

Authors:  D A B Rex; Nupur Agarwal; T S Keshava Prasad; Richard K Kandasamy; Yashwanth Subbannayya; Sneha M Pinto
Journal:  J Cell Commun Signal       Date:  2019-12-20       Impact factor: 5.782

9.  A novel role for IkappaBzeta in the regulation of IFNgamma production.

Authors:  Raquel M Raices; Yashaswini Kannan; Vedavathi Bellamkonda-Athmaram; Sudarshan Seshadri; Huating Wang; Denis C Guttridge; Mark D Wewers
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

10.  Association of interleukin-18 genotypes (-607C > A) and (-137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinoma.

Authors:  Taqveema Ali; Roli Saxena; Isha Rani; Renuka Sharma; Deepti More; Rajendra Ola; Stuti Agarwal; Yogesh Kumar Chawla; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2021-06-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.